Cell Signaling – Page 2 – Therapy with DNA repair inhibitors in early phase clinical trials

3C), but the manifestation levels did not change by more than 2 fold during the four time points in the 48 hours post blood feeding

October 21, 2021 climat2050

3C), but the manifestation levels did not change by more than 2 fold during the four time points in the 48 hours post blood feeding.

Read More

Ufd1 enhances the E3 activity of gp78 and accelerates the degradation of HMGCR (17)

September 30, 2021 climat2050

Ufd1 enhances the E3 activity of gp78 and accelerates the degradation of HMGCR (17). mevalonate pathway, promote ubiquitination and degradation of the HMGCR protein (10,C12).

Read More